Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02890524
Other study ID # Tokushima #2053
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date July 2014
Est. completion date March 2018

Study information

Verified date April 2019
Source University of Tokushima
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The investigators will investigate whether the night guard can suppress the development of recurrent aphthous stomatitis (RAS). The investigators will record the patients' oral condition for 60 days before and after intervention with the night guard made of Ethylene-Vinyl Acetate copolymer (EVA). The patients' saliva will be analyzed for measurement of inflammatory cytokines or oxidative stress.


Description:

The study involved 20 patients (8 male and 12 female) with RAS. These patients suffered from RAS at least once a month. The investigators will record their oral condition for 60 days before and after intervention with the night guard made of EVA. Their saliva will be analyzed for further studies including measurement of inflammatory cytokines or oxidative stress.


Recruitment information / eligibility

Status Completed
Enrollment 20
Est. completion date March 2018
Est. primary completion date March 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A and older
Eligibility Inclusion Criteria:

- Patients suffered from recurrent aphthous stomatitis at least once a month

Exclusion Criteria:

- People do not have a experience of recurrent aphthous stomatitis

Study Design


Related Conditions & MeSH terms


Intervention

Device:
night guard
60 days before and after intervention with the night guard
placebo night guard
60 days before and after intervention with the placebo night guard

Locations

Country Name City State
Japan Tada Dental Clinic Kakogawa Hyogo
Japan Tokushima University Hospital Tokushima

Sponsors (1)

Lead Sponsor Collaborator
University of Tokushima

Country where clinical trial is conducted

Japan, 

Outcome

Type Measure Description Time frame Safety issue
Primary number of developed aphthous stomatitis through study completion, an average of 1 year
Secondary days until healing through study completion, an average of 1 year
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05542173 - Efficacy and Safety of BALI Association in the Treatment of Aphthous Ulcerations Phase 3
Completed NCT04884464 - Hyaluronic Acid in Counteracting Aphthous Stomatitis
Withdrawn NCT02535962 - Probiotics and Corticosteroids for Treating Periodic Fever, Aphthous Stomatitis, Pharyngitis, Cervical Adenitis (PFAPA) Phase 2
Completed NCT01293968 - Therapeutic Effects of "Ibuprofen, Diphenhydramine and Aluminium MgS" on Recurrent Aphthous Stomatitis Phase 2
Completed NCT04677062 - Safety, Galenic Acceptability and Efficacy of GV-328 Lozenges in Children With Oral Aphthosis N/A
Completed NCT02789605 - Effectiveness and Safety of Lactobacillus Rhamnosus Lcr35® in the Treatment of Recurrent Aphthous Stomatitis Phase 2
Recruiting NCT05772338 - Efficacy and Safety of BNP105 in the Treatment of Recurrent Aphthous Stomatitis N/A
Completed NCT00527306 - Prevention of Recurrent Aphthous Stomatitis Using Vitamins Phase 3
Completed NCT00001601 - Evaluation and Treatment of Oral Soft Tissue Diseases N/A
Completed NCT01210014 - Systemic Zinc Sulphate in Treatment of Recurrent Aphthous Ulcerations:A Doubleblind, Placebo Controled Study Phase 2